OMRON Healthcare, a medical device company, announced additional investment in India-based AI MedTech startup Tricog Health India. This is OMRON Healthcare’s second wave of investment in Tricog, following an initial investment in March 2023, further strengthening the partnership to accelerate business growth.
Since 2023, OMRON Healthcare and Tricog Health have been working together on the development and launch of KeeboHealth, a remote monitoring service for heart-failure patients that integrates Tricog’s AI-based ECG analytics with OMRON’s connected electrocardiograph devices. By analyzing home-recorded ECG and blood pressure data, and sharing the results with physicians, the service improves diagnostic efficiency and helps prevent post-treatment recurrence.
Through this new investment, OMRON Healthcare will further strengthen its strategic partnership with Tricog Health, setting ambitious joint goals to introduce solutions aligned with local clinical needs in India, while advancing the development and delivery of ever-higher-value devices and services. This collaboration is also an important component of OMRON Healthcare’s corporate mission, Going for ZERO, which sets the ambitious goal of a future in which adverse cerebrovascular and cardiovascular events are a thing of the past.
Founded in 2014 by Dr Charit Bhograj, Tricog is an AI company building foundation models for cardiovascular diagnosis and management.
Tricog Health fuses cutting-edge AI analysis built from more than a decade of ECG data, with the human expertise of over 100 in-house clinical specialists to facilitate the timely provision of preventive care for those who need it.
Tricog’s multimodal models interpret ECG and ultrasound signals to enable real-time detection of up to 140 heart conditions and to activate standardised care pathways from home to hospital via the Keebo cardiovascular AI platform.
Tricog’s solutions, including InstaECG, InstaEcho, and Keebo, are deployed across 12,500+ clinics and hospitals in 12+ countries (Asia and Africa). To date, the company has screened 31 million+ patients and identified ~1,000,000 critical cases who then entered guideline-based care, making Tricog among the world’s most widely used systems for cardiovascular detection and management. In partnership with global device leaders and health systems, Tricog is advancing earlier diagnosis, GDMT optimisation, and ACS/rhythm pathways to make quality heart care accessible to 100 million people by 2030.
Charit Bhograj, CEO, Tricog Health, said, “Together, we will accelerate a hospital-to-home rollout, pairing OMRON’s world-class medical devices with Keebo™ AI-powered, guideline-aware workflows, to streamline diagnosis, improve cardiovascular management, and reduce avoidable healthcare costs across Asia, Africa and other key international markets.”
Ayumu Okada, President and CEO, OMRON Healthcare, said, “India is at a pivotal moment when it comes to facing cardiovascular disease, and we are proud to deepen our partnership with Tricog Health to bring advanced remote patient monitoring services and early detection to patients nationwide. We take a proactive approach to strategic partnerships, working with collaborators who help us move faster and innovate further. Combining Tricog’s AI-driven cardiology platform with OMRON’s medical technology will improve outcomes, reduce risk and bring us closer to our global vision of ‘Going for ZERO’ cardiovascular events.”
